Recent Advances in the Management of Multiple Myeloma: Clinical Impact Based on Resource-stratification. Consensus Statement of the Asian Myeloma Network at the 16th International Myeloma Workshop

Recent Advances in the Management of Multiple Myeloma: Clinical Impact Based on Resource-stratification. Consensus Statement of the Asian Myeloma Network at the 16th International Myeloma Workshop

10.1080/10428194.2018.1427858

Saved in:

Bibliographic Details
Main Authors:	Daryl Tan, Jae Hoon Lee, Wenming Chen, Kazuyuki Shimizu, Jian Hou, Kenshi Suzuki, Weerasak Nawarawong, Shang-Yi Huang, James Chim, Kihyun Kim, Pankaj Malhotra, Lalit Kumar, Wee Joo Chng, Brian Durie
Other Authors:	MEDICINE
Format:	Others
Published:	Taylor & Francis 2018
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/149936
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

IMWG consensus on risk stratification in multiple myeloma
by: Chng, W.J., et al.
Published: (2016)

Clinical profiles of multiple myeloma in asia-an asian myeloma network study
by: Kim, K., et al.
Published: (2016)

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
by: Liu, Jin, et al.
Published: (2022)

Management of multiple myeloma in asia: Resource-stratified guidelines
by: Tan, D., et al.
Published: (2016)

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network
by: Soekojo, Cinnie Yentia, et al.
Published: (2022)

Myeloma Therapy
by: Judith E. Karp, Sagar Lonial
Published: (2017)

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma
by: Jia, Yunlu, et al.
Published: (2021)

Immunotherapy in Multiple Myeloma
by: Soekojo, Cinnie Yentia, et al.
Published: (2022)

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
by: Moreau, Philippe, et al.
Published: (2021)

Epigenetic silencing of long non-coding RNABM742401in multiple myeloma: impact on prognosis and myeloma dissemination
by: Li, Zhenhai, et al.
Published: (2022)

Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries
by: Vania T.M. Hungria, et al.
Published: (2019)

The Use of Bortezomic for Multiple Myeloma
by: Siprianus Ugroseno Yudho Bintoro
Published: (2017)

New drugs in multiple myeloma
by: Chutima Kunacheewa, et al.
Published: (2020)

Centrosomes and myeloma; aneuploidy and proliferation
by: Chng, W.J., et al.
Published: (2016)

Implications of heterogeneity in multiple myeloma
by: De Mel S., et al.
Published: (2018)

Metabolic Vulnerabilities in Multiple Myeloma
by: Lim, Julia SL, et al.
Published: (2022)

The Molecular Biology of Multiple Myeloma
by: Chng, W.J., et al.
Published: (2016)

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
by: Murray, David L, et al.
Published: (2022)

Efek Antiproliferatif Pentagamavunon-O Terhadap Sel Myeloma: Atniproliferative Effect of Pentagamanunon-O on Myeloma Cells
by: Perpustakaan UGM, i-lib
Published: (2004)

Disease, Diagnosis & Treatment of Multiple Myeloma
by: Siprianus Ugroseno Yudho Bintoro
Published: (2017)

Batezomib in The lnitial Treatment of Multiple Myeloma
by: Ugroseno Yudho Bintoro, Siprianus
Published: (2014)

STUDIES ON THE METABOLISM OF MYELOMA AND HYBRIDOMA CELLS
by: LIOU KIAN FONG
Published: (2020)

miRNA deregulation in multiple myeloma
by: Bi C.L., et al.
Published: (2018)

Circle hairs in a patient with multiple myeloma
by: Preeyachat Limtong, et al.
Published: (2022)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023)

A unique rhinologic manifestation of multiple myeloma
by: Seah, Jun Jie, et al.
Published: (2022)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023)

Potential clinical application of genomics in multiple myeloma
by: Soekojo, C.Y, et al.
Published: (2020)

MMSET: Role and therapeutic opportunities in multiple myeloma
by: Xie Z., et al.
Published: (2018)

Management of treatment-emergent peripheral neuropathy in multiple myeloma
by: Richardson, P.G., et al.
Published: (2016)

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: An analysis of the Singapore multiple myeloma study group
by: Tan, D., et al.
Published: (2016)

Cytogenetic profiles and their clinical significance in relapsed multiple myeloma
by: Lin, Qian Yu
Published: (2023)

Multiple myeloma: the National University Hospital (NUH) experience.
by: Lim, H.L., et al.
Published: (2016)

Clinical and biological significance of RAS mutations in multiple myeloma
by: Chng, W.J., et al.
Published: (2011)

Activities of the cytokine receptor CD137 in multiple myeloma
by: KOH LIANG KAI
Published: (2010)

Malignant pleural effusion in a patient with multiple myeloma
by: Lau, L.G., et al.
Published: (2016)

IDENTIFY FUNCTIONAL PROTEINS INTERACTING WITH MMSET IN MULTIPLE MYELOMA
by: CHOOI JING YUAN
Published: (2018)

Targeting nf-κb signaling for multiple myeloma
by: Wong, A.H.-H., et al.
Published: (2021)

Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma
by: Razak, R.A., et al.
Published: (2016)

ELUCIDATING THE ONCOGENIC ROLES OF MARCH5 IN MULTIPLE MYELOMA
by: HAMED BASHIRI
Published: (2024)